Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5539648 | 0.73 | CYP2A6 (0.38) | ADRA2AADRA2BCYP2A6SLC6A2SLC6A4 | |
| SCHEMBL2263913 | 0.70 | CYP2A6 (0.57) | ADRA2AADRA2BCYP2A6 | |
| SCHEMBL3617338 | 0.68 | NFE2L2 (0.48) | CYP2A6PTGS1PTGS2 | |
| SCHEMBL3617335 | 0.68 | NFE2L2 (0.48) | CYP2A6PTGS1PTGS2 | |
| SCHEMBL9113126 | 0.67 | ADRA2A (0.33) | ADRA2AADRA2BCYP2A6 | |
| SCHEMBL3812893 | 0.67 | TUBB4A (0.35) | ADRA2AADRA2BCYP2A6SLC6A2SLC6A4 | |
| SCHEMBL29945210 | 0.66 | GABRA1 (0.41) | ADRA2AADRA2BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL826728 | 0.66 | GABRA1 (0.41) | ADRA2AADRA2BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9112211 | 0.65 | CYP2A6 (0.34) | ADRA2AADRA2BCYP2A6SLC6A2SLC6A4 | |
| SCHEMBL3066996 | 0.65 | LMNA (0.34) | ADRA2AADRA2BCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0670831-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995009159-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-04-06 | — | — | WO | disclosed |